Consolidated Statements Of Earnings (USD $) In Millions, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net sales	$ 9,021	$ 8,657	$ 8,307
Cost of sales	2,977	2,781	2,811
Gross profit	6,044	5,876	5,496
Research, development and engineering expenses	536	471	462
Selling, general and administrative expenses	4,066	3,466	3,150
Intangible asset amortization	138	123	122
Restructuring charges	48	75	76
Total operating expenses	4,788	4,135	3,810
Operating income	1,256	1,741	1,686
Other income (expense), net	(44)	(36)
Earnings before income taxes	1,212	1,705	1,686
Income taxes	206	407	341
Net earnings	$ 1,006	$ 1,298	$ 1,345
Net earnings per share of common stock:
Basic net earnings per share of common stock	$ 2.66	$ 3.41	$ 3.48
Diluted net earnings per share of common stock	$ 2.63	$ 3.39	$ 3.45
Weighted-average shares outstanding—in millions:
Basic	378.6	380.6	386.5
Net effect of dilutive employee stock options	3.5	2.4	3.0
Diluted	382.1	383.0	389.5
Anti-dilutive shares excluded from the calculation of net effect of dilutive employee stock options		6.4	7.8